ClinicalTrials.gg

Program

Anaprazole Sodium enteric-coated tablet

Also written as “[14C]-Anaprazole Sodium enteric-coated capsule”.

Its studies are mostly in Hepatic Insufficiency, led by Sihuan Pharmaceutical Holdings Group.

Furthest: phase 4, since Jan 7, 20265 company-led studies, 2 open or runningNext primary completion: Feb 19, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sihuan Pharmaceutical Holdings Group52 open or runningphase 4since Jan 7, 2026Jun 30, 2020Feb 19, 2027phase 3 · NCT07606833

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 30, 2020First studies: 2 phase 1 studies in Healthy VolunteersFirst studyNCT04471922, NCT04466748
  2. Jul 15, 2020Phase 1 study in Healthy Male VolunteersNCT04476394 · 6 enrolled
  3. Jan 7, 2026Phase 4 study in Hepatic InsufficiencyNCT07345689 · 60 planned · China
  4. May 19, 2026Phase 3 study in HELICOBACTER PYLORI INFECTIONSNCT07606833 · 556 planned · China

Ahead

  1. Feb 19, 2027Primary completion: phase 3 study in HELICOBACTER PYLORI INFECTIONSNCT07606833

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07606833HELICOBACTER PYLORI INFECTIONS · China3Not yet recruitingFeb 19, 2027556
NCT07345689Hepatic Insufficiency · China4Not yet recruitingOct 30, 202660
NCT04476394Healthy Male Volunteers1UNKNOWNSep 30, 20206
NCT04471922Healthy Volunteers · China1CompletedMar 28, 201945
NCT04466748Healthy Volunteers1CompletedDec 29, 201536

How it is read

Names in the registry

  • “Anaprazole Sodium enteric-coated tablet”, 4 entries
  • “[14C]-Anaprazole Sodium enteric-coated capsule”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.